MIEF2 (Mitochondrial Elongation Factor 2), also known as MiD50 (Mitochondrial Dynamics Protein of 50 kDa) and SMCR7, encodes a critical mitochondrial outer membrane protein that plays essential roles in regulating mitochondrial dynamics. Mitochondria are dynamic organelles that continuously undergo fission (division) and fusion (merging), a process essential for cellular health, energy metabolism, and quality control. MIEF2 functions as a molecular adaptor that recruits the large GTPase Drp1 (Dynamin-related protein 1) to the mitochondrial surface to initiate fission.
The balance between mitochondrial fission and fusion is critical for neuronal survival. In neurodegenerative diseases including Parkinson's disease (PD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS), mitochondrial dynamics are profoundly disrupted. MIEF2 sits at the intersection of these pathways, making it an important protein for understanding disease mechanisms and developing therapeutic interventions.
This gene has attracted significant attention because of its direct interaction with the PINK1/Parkin pathway, which is central to familial PD. Loss of MIEF2 function impairs mitophagy (mitochondrial quality control), leading to accumulation of dysfunctional mitochondria—a hallmark of neurodegeneration.
| MIEF2 — Mitochondrial Elongation Factor 2 |
|---|
| Gene Symbol | MIEF2 |
| Protein Product | MiD50 (Mitochondrial dynamics protein of 50 kDa) |
| Also Known As | SMCR7, Mid51 |
| Chromosome | 17p13.1 |
| NCBI Gene ID | [84790](https://www.ncbi.nlm.nih.gov/gene/84790) |
| Ensembl ID | ENSG00000146070 |
| UniProt ID | [Q8N5Z0](https://www.uniprot.org/uniprot/Q8N5Z0) |
| Associated Diseases | [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Mitochondrial Disorders |
¶ Molecular Function and Mechanism
¶ Structure and Topology
MIEF2 (MiD50) is a mitochondrial outer membrane protein with several key features:
- N-terminal mitochondrial targeting sequence: Directs protein to mitochondria
- Transmembrane domain: Anchors protein in the outer membrane
- Cytosolic domain: Interacts with Drp1 and other proteins
- Flexible linker region: Connects membrane and cytosolic domains
Mitochondrial fission is executed by the large GTPase Drp1, which forms ring-like structures around mitochondria to mediate division. However, Drp1 must first be recruited to the mitochondrial surface. MIEF2 performs this critical function:
- Drp1 recruitment: MIEF2 binds Drp1 in the cytosol and brings it to mitochondrial fission sites
- Oligomerization: MIEF2 oligomerizes to form a platform for Drp1 assembly
- GTPase activation: MIEF2 stimulates Drp1 GTP hydrolysis, enabling membrane constriction
- Coordination with MiD49: MIEF2 works with its paralog MiD49 (encoded by MIEF1) to fine-tune fission efficiency
MIEF2 directly interfaces with the PINK1/Parkin mitophagy pathway:
- PINK1 phosphorylation: Upon mitochondrial damage, PINK1 accumulates on the outer membrane
- Parkin recruitment: PINK1 phosphorylates ubiquitin and Parkin, activating it
- Mitochondrial fission: Activated Parkin ubiquitinates MIEF2 and other fission proteins
- Quality control: Fission enables segregation of damaged mitochondrial segments for degradation
This connection explains why MIEF2 dysfunction particularly impacts dopaminergic neurons, which rely heavily on mitophagy for survival.
MIEF2 is widely expressed but shows particular importance in tissues with high energy demands:
| Tissue |
Expression |
Notes |
| Brain |
High |
Neurons require constant energy |
| Heart |
High |
Continuous cardiac function |
| Muscle |
High |
High metabolic demand |
| Liver |
Moderate |
Metabolic functions |
| Kidney |
Moderate |
Various transport functions |
Within neurons, MIEF2 localizes to:
- Mitochondrial outer membrane: Throughout neuronal processes
- Synaptic mitochondria: Enriched at synapses where energy demand is highest
- Axonal mitochondria: Critical for axonal maintenance
This distribution explains why MIEF2 dysfunction particularly impacts synaptic function and axonal transport.
Mitophagy is a specialized form of autophagy that selectively removes damaged mitochondria. This process is essential for:
- Removing dysfunctional mitochondria
- Maintaining cellular health
- Preventing accumulation of ROS-producing organelles
MIEF2 contributes to mitophagy through:
- Fission initiation: Generating small mitochondria amenable to engulfment
- PINK1/Parkin interaction: Direct regulation by mitophagy pathway
- Ubiquitination: Being itself ubiquitinated by Parkin
- ATG protein recruitment: Coordinating autophagosome formation
Loss of MIEF2 function impairs mitophagy, leading to accumulation of dysfunctional mitochondria.
The fission/fusion cycle integrates with quality control:
- Fusion: Allows mixing of mitochondrial contents, complementing function
- Fission: Generates units for possible removal
- Selective removal: Damaged segments are eliminated via mitophagy
- Rejuvenation: Healthy mitochondria resume fusion and function
MIEF2 mutations disrupt this cycle, leading to progressive mitochondrial dysfunction.
PD is strongly linked to mitochondrial dysfunction. MIEF2 sits at the interface of the PINK1/Parkin pathway:
- PINK1 mutations: Cause early-onset familial PD
- Parkin mutations: Cause autosomal recessive PD
- MIEF2 regulation: Both pathways affect MIEF2 function
Studies show that:
- MIEF2 is downregulated in PD patient brain
- Overexpression of MIEF2 can protect dopaminergic neurons
- Loss of MIEF2 enhances vulnerability to mitochondrial toxins
Dopaminergic neurons in the substantia nigra are particularly vulnerable:
- High energy requirements
- Complex axonal arborization
- Reliance on mitophagy for survival
- Exposure to oxidative stress from dopamine metabolism
MIEF2 dysfunction contributes to the selective vulnerability of these neurons.
MIEF2 represents a therapeutic target for PD:
- Gene therapy: Increasing MIEF2 expression
- Small molecule activators: Enhancing MIEF2 function
- Combination approaches: Targeting multiple aspects of mitophagy
In AD, amyloid-beta (Aβ) directly affects mitochondrial dynamics:
- Aβ accumulation: In mitochondria and at synapses
- Drp1 recruitment: Enhanced, leading to excessive fission
- Mitochondrial fragmentation: Characteristic finding in AD neurons
- Energy deficits: Resulting from impaired mitochondrial function
MIEF2 contributes to these processes through its regulation of fission.
Tau pathology also impacts mitochondrial dynamics:
- Tau mislocalization: To dendritic mitochondria
- Drp1 recruitment: Tau interacts with Drp1
- Fission/fusion imbalance: Contributing to dysfunction
Approaches targeting mitochondrial dynamics in AD include:
- Drp1 inhibitors: Reduce excessive fission
- MIEF2 modulators: Normalize dynamics
- Combination approaches: With anti-amyloid therapies
ALS also features prominent mitochondrial abnormalities:
- Motor neuron vulnerability: High energy requirements
- Mitochondrial fragmentation: Observed in models and patients
- Quality control failure: Impaired mitophagy
MIEF2 dysfunction may contribute to ALS pathogenesis:
- Enhanced fission
- Impaired quality control
- Energy deficits in motor neurons
Mitochondrial dysfunction is a hallmark of Huntington's disease:
- Mutant huntingtin: Affects mitochondrial dynamics proteins
- Drp1 hyperactivity: Contributes to fragmentation
- Energy deficits: Impaired ATP production
MIEF2 may participate in these mechanisms.
Primary mitochondrial diseases also involve MIEF2:
- Leigh syndrome: Often involves fission defects
- MELAS: Mitochondrial encephalomyopathy
- External ophthalmoplegia: CPEO
MIEF2 works closely with its paralog MiD49 (encoded by MIEF1):
- Heterodimer formation: Complexes provide more efficient recruitment
- Functional redundancy: Partial compensation possible
- Differential regulation: Each responds to different signals
Drp1 is the primary effector of MIEF2 function:
- Direct binding: Through MIEF2 cytosolic domain
- GTPase regulation: Modulates Drp1 activity
- Oligomerization: Promotes Drp1 assembly
MIEF2 interacts with the broader mitochondrial dynamics network:
- OPA1: Inner membrane fusion protein
- Mfn1/2: Outer membrane fusion proteins
- Fis1: Alternative fission adaptor
MIEF2 and related proteins represent therapeutic targets:
| Strategy |
Approach |
Status |
| Gene therapy |
Increase MIEF2 expression |
Preclinical |
| Drp1 inhibitors |
Reduce excessive fission |
Clinical trials |
| MIEF2 modulators |
Direct activation |
Research |
| Combination approaches |
Multi-target strategies |
Emerging |
MIEF2 may serve as a biomarker:
- Blood cells: Peripheral measure
- CSF: Central nervous system involvement
- Imaging: PET-based approaches (experimental)
Key models for studying MIEF2:
- Knockout mice: Embryonic lethal, highlighting essential function
- Conditional knockouts: Tissue-specific deletion
- iPSC models: Neurons from patients
Tools for studying mitochondrial dynamics:
- Mdivi-1: Drp1 inhibitor
- Mitochondrial division inhibitors: Related compounds
- Fission inducers: For controlled studies
¶ Outstanding Questions
- Cell-type specificity: How does MIEF2 function differ across neuron types?
- Therapeutic modulation: Can selective enhancement be achieved?
- Biomarker utility: Is MIEF2 a viable disease marker?
- Combination therapy: Optimal approaches with other targets?
- Single-cell approaches: Cell-type specific dysfunction mapping
- Structural biology: Understanding MIEF2-Drp1 interaction
- Gene therapy: Viral vector approaches for delivery